Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study

作者：Joseph J. Eron, Susan J. Little, Gordon Crofoot, Paul Cook, Peter Ruane, Dushyantha Jayaweera, Laurie A. VanderVeen, Edwin DeJesus, Yanan Zheng, Anthony Mills, Hailin Huang, Sarah Waldman, Moti Ramgopal, Linda Gorgos, Sean E Collins, Jared M. Baeten, Marina Caskey · 发表于：The Lancet HIV · 年份：2024 · DOI：10.1016/s2352-3018(23)00293-x · 被引用次数：48 · 研究领域：HIV/AIDS drug development and treatment、HIV Research and Treatment、HIV/AIDS Research and Interventions